Evidence map›Paper›PMID 41080190›Full record

ArticleNeuro-oncology practice2025

End-of-life care in patients with glioblastoma after early advance care planning.

Lara Fritz, Esther Zaloumis, Hanneke Zwinkels, Jaap C Reijneveld, Maaike J Vos, H Roeline W Pasman, Linda Dirven, Johan A F Koekkoek, Martin J B Taphoorn

Abstract read
In one paragraph

Article in Neuro-oncology practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lara FritzDepartment of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
Esther ZaloumisDepartment of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Hanneke ZwinkelsDepartment of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
Jaap C ReijneveldDepartment of Neurology, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands.
Maaike J VosDepartment of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
H Roeline W PasmanDepartment of Public and Occupational Health,Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Expertise Center for Palliative Care Amsterdam, Amsterdam, The Netherlands.
Linda DirvenDepartment of Neurology, Leiden University Medical Center, Leiden, The Netherlands.ORCID https://orcid.org/0000-0001-9157-9895
Johan A F KoekkoekDepartment of Neurology, Leiden University Medical Center, Leiden, The Netherlands.ORCID https://orcid.org/0000-0002-3648-9616
Martin J B TaphoornDepartment of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We aimed to evaluate the preferred and received end-of-life (EoL) care in glioblastoma patients who participated in a local nurse-led advance care planning (ACP) program, as well as the perceived quality of care. Methods: Twelve proxies of patients with glioblastoma who participated in an ACP program completed a study-specific questionnaire after the patient deceased, comprising the following topics: organization of EoL care, patient's preferences and wishes, received care during the last 3 months, and proxies' experiences with EoL care. The outcomes were compared with those from a historical cohort of Dutch patients with glioblastoma ( Results: Nine out of 12 patients lived at home 3 months before death and most (8/12) died at home. In 11/12 cases, the general practitioner was responsible for EoL care in the last week before death. Proxies indicated that most patients rated their quality of received EoL care as very good to excellent in the last 3 months and last week before death (67% and 75%, respectively), that 8/12 patients died with dignity and that all proxies were involved as much as they wanted in decision-making. One-third of the patients in the ACP cohort were relocated at least once in the last 3 months versus 48% of the patients in the historical cohort. Conclusions: Despite the limited number of participants, this study suggests that a nurse-led ACP program has a positive impact on several aspects of EoL care for patients with glioblastoma.

Indexed as

advance care planningbrain tumorend-of-lifeglioblastomaplace of death

Identifiers

PMID41080190
PMCPMC12508743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.